ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Quell Therapeutics Limited

Quell Therapeutics Limited is an active company incorporated on 19 March 2019 with the registered office located in London, Greater London. Quell Therapeutics Limited was registered 6 years ago.
Status
Active
Active since incorporation
Company No
11890040
Private limited company
Age
6 years
Incorporated 19 March 2019
Size
Medium
Turnover is under £54M
Under 250 employees
Confirmation
Submitted
Dated 28 April 2025 (8 months ago)
Next confirmation dated 28 April 2026
Due by 12 May 2026 (4 months remaining)
Last change occurred 7 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (8 months remaining)
Contact
Address
3rd Floor, Translation & Innovation Hub
84 Wood Lane
London
W12 0BZ
England
Same address for the past 5 years
Telephone
020 70969012
Email
Unreported
Website
Unreported
People
Officers
9
Shareholders
93
Controllers (PSC)
1
Director • Venture Capitalist • British • Lives in UK • Born in Oct 1965
Director • Financial Analyst • American • Lives in United States • Born in Feb 1976
Director • Investor • Italian,canadian • Lives in England • Born in Jan 1979
Director • Self Employed • American • Lives in United States • Born in May 1958
Director • University Professor • British • Lives in UK • Born in Dec 1951
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
SV Health Investors UK Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Pulmocide Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Autifony Therapeutics Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Sitryx Therapeutics Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Enara Bio Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Alchemab Therapeutics Ltd
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Mestag Therapeutics Ltd
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Beacon Therapeutics Holdings Limited
Dr Elisa Michela Petris is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2020–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£60.47M
Decreased by £46.25M (-43%)
Turnover
£43.83M
Increased by £34.67M (+378%)
Employees
146
Increased by 8 (+6%)
Total Assets
£90.77M
Decreased by £36.78M (-29%)
Total Liabilities
-£12.18M
Decreased by £32.94M (-73%)
Net Assets
£78.59M
Decreased by £3.85M (-5%)
Debt Ratio (%)
13%
Decreased by 21.95% (-62%)
Latest Activity
Shares Cancelled
24 Days Ago on 15 Dec 2025
Own Shares Purchased
24 Days Ago on 15 Dec 2025
Own Shares Purchased
24 Days Ago on 15 Dec 2025
Shares Cancelled
1 Month Ago on 19 Nov 2025
Mr Luke Beshar Appointed
5 Months Ago on 24 Jul 2025
Full Accounts Submitted
5 Months Ago on 23 Jul 2025
Annette Clancy Appointed
6 Months Ago on 13 Jun 2025
Confirmation Submitted
7 Months Ago on 2 Jun 2025
Rachel Brooke Mears Resigned
7 Months Ago on 31 May 2025
Full Accounts Submitted
1 Year 2 Months Ago on 12 Oct 2024
Get Credit Report
Discover Quell Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Cancellation of shares. Statement of capital on 31 October 2025
Submitted on 15 Dec 2025
Purchase of own shares.
Submitted on 15 Dec 2025
Purchase of own shares.
Submitted on 15 Dec 2025
Cancellation of shares. Statement of capital on 31 October 2025
Submitted on 19 Nov 2025
Change of share class name or designation
Submitted on 1 Oct 2025
Particulars of variation of rights attached to shares
Submitted on 30 Sep 2025
Second filing for the appointment of Mr Luke Beshar as a director
Submitted on 1 Sep 2025
Appointment of Mr Luke Beshar as a director on 24 July 2025
Submitted on 29 Aug 2025
Full accounts made up to 31 December 2024
Submitted on 23 Jul 2025
Appointment of Annette Clancy as a director on 13 June 2025
Submitted on 27 Jun 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year